Shift to Everolimus (RAD) Kidney Sparing Study
Trial of RAD001 in Triple Negative Metastatic Breast Cancer
Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus
Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.
† Study has passed its completion date and status has not been verified in more than two years.